Evidence map›Paper›PMID 19083193›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2009

The role of HSP70 on ENPP1 expression and insulin-receptor activation.

Antonella Marucci, Giuseppe Miscio, Libera Padovano, Watip Boonyasrisawat, Jose C Florez, Alessandro Doria, Vincenzo Trischitta, Rosa Di Paola

Abstract read
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. A Workflow Guide to RNA-Seq Analysis of Chaperone Function and Beyond.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  3. Article
  4. A Workflow Guide to RNA-seq Analysis of Chaperone Function and Beyond.Methods in molecular biology (Clifton, N.J.) · 2018
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Antonella Marucci *Research Unit of Diabetes and Endocrine Diseases, Scientific Institute, Poliambulatorio Giovanni Paolo II, Viale Padre Pio, 71013 San Giovanni Rotondo, Italy.
Giuseppe Miscio *Research Unit of Diabetes and Endocrine Diseases, Scientific Institute, Poliambulatorio Giovanni Paolo II, Viale Padre Pio, 71013 San Giovanni Rotondo, Italy.
Libera PadovanoResearch Unit of Diabetes and Endocrine Diseases, Scientific Institute, Poliambulatorio Giovanni Paolo II, Viale Padre Pio, 71013 San Giovanni Rotondo, Italy.
Watip BoonyasrisawatResearch Division, Joslin Diabetes Center, Boston, MA, USA.
Jose C FlorezDepartment of Medicine, Harvard Medical School, Boston, MA, USA.
Alessandro DoriaResearch Division, Joslin Diabetes Center, Boston, MA, USA.
Vincenzo Trischitta *Research Unit of Diabetes and Endocrine Diseases, Scientific Institute, Poliambulatorio Giovanni Paolo II, Viale Padre Pio, 71013 San Giovanni Rotondo, Italy.
Rosa Di Paola *Research Unit of Diabetes and Endocrine Diseases, Scientific Institute, Poliambulatorio Giovanni Paolo II, Viale Padre Pio, 71013 San Giovanni Rotondo, Italy.
Nuovo Ospedale San Giovanni di Dio · ITJoslin Diabetes Center · USHarvard University · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI LAURIE J GOODYEAR · 1986 to 2026
$50.5M
Variability in Adipokine Genes and AtherosclerosisR01HL073168 · NHLBI · JOSLIN DIABETES CENTER · PI DORIA, ALESSANDRO · 2003 to 2012
$5.8M
Search for new MODY genes and molecular studies of their function in beta cellsR01DK055523 · NIDDK · JOSLIN DIABETES CENTER · PI DORIA, ALESSANDRO, KULKARNI, ROHIT N. · 1998 to 2014
$4.0M
Genetic variation in drug targets for type 2 diabetesK23DK065978 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI FLOREZ, JOSE CARLOS · 2004 to 2008
$653k
NHLBI NIH HHS HL73168NHLBI NIH HHS R01 HL073168NIDDK NIH HHS DK36836NIDDK NIH HHS DK55523NIDDK NIH HHS K23 DK065978NIDDK NIH HHS K23 DK65978-04NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK055523NIEHS NIH HHS 27306C2005Telethon E.1239Telethon GGP02423
6 · The paper itself

Abstract

Ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) inhibits insulin-receptor (IR) signaling and, when over-expressed, induces insulin resistance in vitro and in vivo. Understanding the regulation of ENPP1 expression may, thus, unravel new molecular mechanisms of insulin resistance. Recent data point to a pivotal role of the ENPP1 3'UTR, in modulating ENPP1 mRNA stability and expression. We sought to identify trans-acting proteins binding the ENPP1-3'UTR and to investigate their role on ENPP1 expression and on IR signaling. By RNA electrophoresis mobility shift analysis and tandem mass spectrometry, we demonstrated the binding of heat shock protein 70 (HSP70) to ENPP1-3'UTR. Through this binding, HSP70 stabilizes ENPP1 mRNA and increases ENPP1 transcript and protein levels. This positive modulation of ENPP1 expression is paralleled by a reduced insulin-induced IR and IRS-1 phosphorylation. Taken together these data suggest that HSP70, by affecting ENPP1 expression, may be a novel mediator of altered insulin signaling.

Indexed as

3' Untranslated RegionsBlotting, WesternCell LineElectrophoretic Mobility Shift AssayGene ExpressionHSP70 Heat-Shock ProteinsHumansInsulinPhosphoric Diester HydrolasesPhosphorylationProtein BindingPyrophosphatasesReceptor, InsulinReverse Transcriptase Polymerase Chain ReactionTandem Mass SpectrometryTransfection3' Untranslated Regionsectonucleotide pyrophosphatase phosphodiesterase 1HSP70 Heat-Shock ProteinsInsulinPhosphoric Diester HydrolasesPyrophosphatasesReceptor, Insulin

Identifiers

PMID19083193
PMCPMC3760425
OpenAlexW2166595162

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.